InventisBio Co Ltd

688382

Company Profile

  • Business description

    InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

  • Contact

    No. 4, Lane 67, Li Bing Road
    Room 210
    Pilot Free Trade Zone
    Shanghai201203
    CHN

    T: +86 2150778527

    http://www.inventisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    185

Stocks News & Analysis

stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.
stocks

A 5-Star US stock to buy with a near-5% yield

Undervalued by 23%, this cheap dividend stock is a top pick in its sector.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,148.5045.400.50%
CAC 407,880.8710.190.13%
DAX 4023,745.065.590.02%
Dow JONES (US)46,293.1245.830.10%
FTSE 1009,299.8415.010.16%
HKSE26,622.88494.681.89%
NASDAQ22,596.81112.740.50%
Nikkei 22545,043.75311.24-0.69%
NZX 50 Index13,132.5620.830.16%
S&P 5006,658.3314.630.22%
S&P/ASX 2008,862.8052.100.59%
SSE Composite Index3,862.5334.430.90%

Market Movers